share_log

Canaccord Genuity Maintains Hold on Staar Surgical, Raises Price Target to $46

Benzinga ·  Apr 8 19:47

Canaccord Genuity analyst Jon Young maintains Staar Surgical (NASDAQ:STAA) with a Hold and raises the price target from $32 to $46.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment